Loading clinical trials...
Loading clinical trials...
A Prospective, Randomized, Double-Blind, Sham-Controlled, Multicenter, Phase 3 Study of OTO-201 Given as a Single Administration for Treatment of Acute Otitis Externa
Conditions
Interventions
12 mg ciprofloxacin
Sham Control
Locations
2
United States
Call Otonomy call center for trial locations
San Diego, California, United States
Call Otonomy call center for trial locations
Saskatoon, Canada
Start Date
June 1, 2016
Primary Completion Date
November 1, 2016
Completion Date
December 1, 2016
Last Updated
October 19, 2020
NCT03196973
NCT01535560
Lead Sponsor
Otonomy, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions